Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11235056
Glycan-masked engineered outer domains of HIV-1 gp120 and their use
granted -
US 11234994
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted -
US 11234967
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
granted -
US 11234960
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 11234976
Methods of using pyruvate kinase activators
granted -
US 11234953
Ketone bodies to protect tissues from damage by ionizing radiation
granted -
US 11234939
Dosage forms comprising a plasma kallikrein inhibitor
granted -
US 11234418
Genetically modified cells, tissues, and organs for treating disease
granted -
US 11236402
Adeno-associated virus virions with variant capsid
granted -
US 11236360
Adeno-associated viruses engineered for selectable tropism
granted -
US 11236338
Antisense-induced exon2 inclusion in acid alpha-glucosidase
granted -
US 11236335
Selective antisense compounds and uses thereof
granted -
US 11236340
Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3)
granted -
US 11236339
Modulation of GYS1 expression
granted -
US 11236175
T cell modifying compounds and uses thereof
granted -
US 11236173
CD38 antibody
granted -
US 11236171
Human monoclonal antibodies specific for FLT3 and uses thereof
granted -
US 11236315
Thermophile peptidoglycan hydrolase fusion proteins and uses thereof
granted -
US 11236301
Thin film cell encapsulation devices
granted -
US 11236166
CD8 binding agents
granted -
US 11236151
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
granted -
US 11236139
Combination immunotherapy
granted -
US 11236152
Neutralizing antibodies to HIV-1 GP41 and their use
granted -
US 11236102
Oxabicycloheptane prodrugs
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.